Evaluation of Handling and Possible Complications Related to the Newly Developed Angular Stable Locking System (ASLS)
ASLS-Pre
Prospective Multicenter Case Series to Evaluate Handling and Possible Complications Related to the Angular Stable Locking System in Patients With Proximal and Distal Tibial, Femoral and Humeral Fractures Treated With Intramedullary Nails
1 other identifier
observational
30
2 countries
4
Brief Summary
In many cases, the existing locking bolts and screws in intramedullary nails do not provide sufficient stability. Due to the play between screw and nail, the reduction can be lost and the instability can result in malunions, nonunions, or pseudoarthrosis. Consequently, secondary angular fracture dislocation (defined as a difference of the angle of 10° or more from the post-operative to the follow-up x-rays) can be observed in approximately 30% of patients after conventional intramedullary nailing of proximal third tibial fractures and in approximately 0-2% in patients with distal third tibial fractures. Therefore, an Angular Stable Locking System for Intramedullary Nails (ASLS) was developed to reduce the risk of secondary loss of reduction by providing axial and angular stability. ASLS provides angular stable fixation between nails and screws with resorbable sleeves used as dowels in the nail locking holes. The present study evaluates the handling of ASLS and the surgeon's compliance as well as any complications occurring during the baseline and the follow-up period in patients with proximal and distal tibial, femoral and humeral fractures treated with intramedullary nails. Furthermore, the relationship of any occurred complications to ASLS will be assessed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Aug 2008
Shorter than P25 for all trials
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2008
CompletedFirst Submitted
Initial submission to the registry
November 17, 2008
CompletedFirst Posted
Study publicly available on registry
November 19, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2009
CompletedJuly 22, 2021
August 1, 2009
11 months
November 17, 2008
July 21, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Surgeon's compliance and handling-oriented questionnaire
During surgery
Secondary Outcomes (3)
Rate of Complications
6 months
General pain and pain at fracture site assessed by VAS
6 months
Walking ability in patients with femoral or tibial fractures using the Parker mobility score
6 months
Study Arms (1)
Surgical
Patients with proximal and/or distal tibial, femoral and/or humeral fractures treated with intramedullary nails and the Angular Stable Locking System(ASLS)
Eligibility Criteria
orthopedic clinics
You may qualify if:
- The patient is ≥ 18 years old
- One of the following bones is fractured so that the fracture is affecting the proximal or the distal third of the bone without affecting the joint surface: Humerus, Femur, Tibia
- The fracture is fixed with one of the following cannulated implants Humerus: Expert HN, Expert PHN. Femur: Expert LFN, Expert RAFN, CFN, DFN, AFN. Tibia: Expert TN, CTN.
- The patient is willing and able to participate in the study follow-up according to the CIP.
- The patient is able to understand and read local language at elementary level.
- The patient is willing and able to give written informed consent to participate in the study.
You may not qualify if:
- The patient is legally incompetent.
- Preexistent malunion or nonunion of the bone that is planned to be treated with ASLS.
- The patient suffers from a polytrauma (multiple injuries, whereof one or the combination of several injuries is life-threatening).
- The patient suffers from active malignancy.
- The patient is affected by drug or alcohol abuse.
- The patient has participated in any other device or drug related clinical trial within the previous month.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
Medizinische Universität Innsbruck, Abteilung Unfallchirurgie und Sporttraumatologie
Innsbruck, 6020, Austria
Charité - Universitätsmedizin Berlin, Centrum für Muskuloskeletale Chirurgie
Berlin, 13353, Germany
Universitätsklinikum Mainz, Klinik und Poliklinik für Unfallchirurgie
Mainz, 55131, Germany
BG Unfallklinik Tübingen
Tübingen, 72076, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dankward Hoentzsch, MD
BG Unfallklinik Tübingen, 72076 Tübingen, Germany
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 17, 2008
First Posted
November 19, 2008
Study Start
August 1, 2008
Primary Completion
July 1, 2009
Study Completion
August 1, 2009
Last Updated
July 22, 2021
Record last verified: 2009-08